New virtual staining solution enhances molecular diagnostics performance, preserves tissue, and accelerates turnaround times NATIONAL HARBOR, Md., Nov. 6, 2025...
BOSTON, Nov. 6, 2025 /PRNewswire/ -- Continuum Recovery Center of Colorado (CRC), a leading Denver-based outpatient addiction treatment provider, announced...
PITTSBURGH, Nov. 6, 2025 /PRNewswire/ -- Assistive Technology Development, Inc. (ATDev) announced today that it is a subcontractor for the...
DOVER, Del., Nov. 6, 2025 /PRNewswire/ -- Mwyngil Therapeutics Inc., a biopharmaceutical company dedicated to developing first-in-class and best-in-class small-molecule therapies...
As an Oracle partner, CereCore will leverage Oracle technologies to drive customer success NASHVILLE, Tenn., Nov. 6, 2025 /PRNewswire/ --...
ZURICH, Nov. 6, 2025 /PRNewswire/ -- NewcelX Ltd. (NASDAQ: NCEL) ("NewcelX" or the "Company"), a biotechnology company advancing transformative therapies for...
Redefining Scalability, Automation, and Clinical Yield in Genomic Interpretation BOZEMAN, Mont., Nov. 6, 2025 /PRNewswire/ -- Golden Helix, Inc. announced the...
Sustained acoustic medicine from ZetrOZ Systems supports recovery when players face intense physical demands, such as an 18-inning game. TRUMBULL,...
An evidence-based look at a modern therapy advancing wellness and regenerative medicine WEST PALM BEACH, FLORIDA / ACCESS Newswire /...
MESA, ARIZONA / ACCESS Newswire / November 6, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), led by CEO Marshall...
Toronto, Ontario--(Newsfile Corp. - November 6, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an...
One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and LiberiaKey takeaways:IAVI's Lassa vaccine candidate...
One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and LiberiaKey takeaways:IAVI's Lassa vaccine candidate...
Results of ongoing investigator-initiated proof-of-concept trial of crofelemer in United Arab Emirates (UAE) demonstrate disease progression modification and reduction of...
Results of ongoing investigator-initiated proof-of-concept trial of crofelemer in United Arab Emirates (UAE) demonstrate disease progression modification and reduction of...
ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer...
ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer...
Integration boosts Grid AI's deployment capacity as AI data-center power demand approaches 50 GW, growing by over 165% through 2030i...
Integration boosts Grid AI's deployment capacity as AI data-center power demand approaches 50 GW, growing by over 165% through 2030i...
VSee explores collaboration with Philippine Tuberculosis Society and former VP Leni Robredo to expand digital health innovation for Naga City...